Knud Schewe

1.9k total citations
47 papers, 1.2k citations indexed

About

Knud Schewe is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Knud Schewe has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 24 papers in Epidemiology and 20 papers in Hepatology. Recurrent topics in Knud Schewe's work include HIV/AIDS Research and Interventions (22 papers), Hepatitis C virus research (20 papers) and HIV Research and Treatment (15 papers). Knud Schewe is often cited by papers focused on HIV/AIDS Research and Interventions (22 papers), Hepatitis C virus research (20 papers) and HIV Research and Treatment (15 papers). Knud Schewe collaborates with scholars based in Germany, United States and United Kingdom. Knud Schewe's co-authors include Christoph Boesecke, Axel Baumgarten, Thomas A. Lutz, Patrick Ingiliz, Bonaventura Clotet, Christian Hoffmann, Christine Katlama, Norbert Bischofberger, Ivanka Krznaric and James F. Rooney and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Knud Schewe

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Knud Schewe Germany	19	867	546	350	300	219	47	1.2k
Maria Franca Pirillo Italy	19	933 1.1×	378 0.7×	127 0.4×	539 1.8×	179 0.8×	58	1.3k
Susan Bersoff‐Matcha United States	13	523 0.6×	305 0.6×	141 0.4×	158 0.5×	168 0.8×	21	1.1k
Marialuisa Partisani France	15	598 0.7×	351 0.6×	146 0.4×	297 1.0×	391 1.8×	38	1.1k
Junko Tanuma Japan	19	814 0.9×	430 0.8×	82 0.2×	330 1.1×	274 1.3×	77	1.2k
Diego Ripamonti Italy	21	969 1.1×	358 0.7×	155 0.4×	630 2.1×	330 1.5×	62	1.2k
David Rey France	21	558 0.6×	741 1.4×	546 1.6×	305 1.0×	136 0.6×	67	1.2k
Rolando M. Viani United States	17	704 0.8×	359 0.7×	108 0.3×	214 0.7×	109 0.5×	45	937
Daisy Maria Machado Brazil	19	584 0.7×	299 0.5×	54 0.2×	296 1.0×	174 0.8×	76	905
Mauro Zaccarelli Italy	25	1.2k 1.4×	498 0.9×	162 0.5×	953 3.2×	218 1.0×	91	1.7k
Antoni Noguera‐Julián Spain	20	821 0.9×	655 1.2×	37 0.1×	328 1.1×	362 1.7×	125	1.5k

Countries citing papers authored by Knud Schewe

Since Specialization

Citations

This map shows the geographic impact of Knud Schewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knud Schewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knud Schewe more than expected).

Fields of papers citing papers by Knud Schewe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knud Schewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knud Schewe. The network helps show where Knud Schewe may publish in the future.

Co-authorship network of co-authors of Knud Schewe

This figure shows the co-authorship network connecting the top 25 collaborators of Knud Schewe. A scholar is included among the top collaborators of Knud Schewe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Knud Schewe. Knud Schewe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ingiliz, Patrick, Christoph Boesecke, Ivanka Krznaric, et al.. (2022). Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis. PLoS ONE. 17(5). e0267853–e0267853. 4 indexed citations

Wolf, Eva, Knud Schewe, Stephan Klauke, et al.. (2020). Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study. Value in Health. 23(10). 1324–1331. 5 indexed citations

Härter, Georg, Christoph D. Spinner, Julia Roider, et al.. (2020). COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection. 48(5). 681–686. 152 indexed citations

Bickel, Markus, Christian Hoffmann, Eva Wolf, et al.. (2020). High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study. Infection. 48(3). 453–461. 10 indexed citations

Hoffmann, Christian, Knud Schewe, Stefan Fenske, et al.. (2019). Short-Term Neuropsychiatric Tolerability of Bictegravir Combined with Emtricitabine/Tenofovir Alafenamide in Clinical Practice. Antiviral Therapy. 25(2). 83–90. 22 indexed citations

Boesecke, Christoph, et al.. (2019). Summary of German‐Austrian HIV PrEP guideline. HIV Medicine. 20(6). 368–376. 10 indexed citations

Vijver, David van de, Charles A. Boucher, Barbara Gunsenheimer‐Bartmeyer, et al.. (2019). Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058. Eurosurveillance. 24(7). 28 indexed citations

Spinner, Christoph D., et al.. (2018). 2016 PREP attitudes in Germany: high awareness and acceptance in MSM at risk of HIV. Infection. 46(3). 405–408. 19 indexed citations

Felden, Johann von, Johannes Vermehren, Patrick Ingiliz, et al.. (2018). High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection. Alimentary Pharmacology & Therapeutics. 47(9). 1288–1295. 35 indexed citations

10.

Sabranski, Michael, Albrecht Stoehr, Andreas Plettenberg, et al.. (2014). Everything fine so far? Physical and mental health in HIV‐infected patients with virological success and long‐term exposure to antiretroviral therapy. Journal of the International AIDS Society. 17(4S3). 19673–19673. 17 indexed citations

11.

Mostardt, Sarah, Jürgen Wasem, Knud Schewe, et al.. (2012). Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study. The European Journal of Health Economics. 14(5). 799–808. 22 indexed citations

12.

Knechten, Heribert, Christoph Stephan, H. Jaeger, et al.. (2011). The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients. European journal of medical research. 16(3). 93–93. 1 indexed citations

13.

Plettenberg, Andreas, N. H. Brockmeyer, Burkhard Haastert, et al.. (2011). Impact of earlier HAART initiation on the immune status and clinical course of treated patients on the basis of cohort data of the German Competence Network for HIV/AIDS. Infection. 39(1). 3–12. 13 indexed citations

14.

Knechten, Heribert, Christoph Stephan, H. Jaeger, et al.. (2010). Safety and Efficacy of a Saquinavir-Containing Antiretroviral Regimen in Previously ART-Naïve or Pretreated but Protease Inhibitor-Naïve HIV-Positive Patients. Infection. 38(2). 108–116. 1 indexed citations

15.

Hahner, Stefanie, Martin Faßnacht, Rolf W. Hartmann, et al.. (2010). Etomidate Unmasks Intraadrenal Regulation of Steroidogenesis and Proliferation in Adrenal Cortical Cell Lines. Hormone and Metabolic Research. 42(7). 528–534. 15 indexed citations

16.

Wolf, Eva, Heiko Jessen, Knud Schewe, et al.. (2009). Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort. European journal of medical research. 14(7). 277–83. 18 indexed citations

17.

Pulido, Federico, Vicente Estrada, Knud Schewe, et al.. (2009). Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks. HIV Clinical Trials. 10(2). 76–87. 25 indexed citations

18.

Nelson, Mark, Christine Katlama, Joan Montaner, et al.. (2007). The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. AIDS. 21(10). 1273–1281. 268 indexed citations

19.

Nattermann, Jacob, Martin Vogel, Thomas Berg, et al.. (2007). Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients. Hepatology. 46(4). 1016–1025. 35 indexed citations

20.

Metzner, Karin J., Pia Rauch, Hauke Walter, et al.. (2005). Detection of minor populations of drug-resistant HIV-1 in acute seroconverters. AIDS. 19(16). 1819–1825. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact